Neoplasm, Unknown Primary
2 clinical trials · Condition
◉ Watch Neoplasm, Unknown Primary
| Record | Firm | Date |
|---|---|---|
| Enabling Genomic Testing in Cancer of Unknown Primary (NCT06695494) | The Christie NHS Foundation Trust | 2024-08-15 |
| Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site (NCT00360360) | SCRI Development Innovations, LLC | 2006-07-01 |
Track Neoplasm, Unknown Primary automatically
Every clearance here is in the API, with alerts when new ones post.